Drug General Information
Drug ID	D03VIS
Former ID	DNC006585
Drug Name	4-tert-butyl-N-phenylthiazol-2-amine
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528047]
Structure		Download 2D MOL 3D MOL
Formula	C13H16N2S
Canonical SMILES	CC(C)(C)C1=CSC(=N1)NC2=CC=CC=C2
InChI	1S/C13H16N2S/c1-13(2,3)11-9-16-12(15-11)14-10-7-5-4-6-8-10/h4-9H,1-3H3,(H,14,15)
InChIKey	OZPRKERRJSPXIW-UHFFFAOYSA-N
PubChem Compound ID	9899450
Target and Pathway
Target(s)	C-Cchemokine receptor type 4	Target Info	Inhibitor	[528047]
KEGG Pathway	Cytokine-cytokine receptor interaction
	Chemokine signaling pathway
	Viral carcinogenesis
PANTHER Pathway	Inflammation mediated by chemokine and cytokine signaling pathway
Reactome	Chemokine receptors bind chemokines
	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Peptide GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 528047	Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3. Epub 2006 Feb 23.Optimization of 2-aminothiazole derivatives as CCR4 antagonists.
Ref 528047	Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3. Epub 2006 Feb 23.Optimization of 2-aminothiazole derivatives as CCR4 antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.